A study of M&A trends and effects on global pharmaceutical industry: using bayer schering pharma as a model
碩士 === 國立政治大學 === 國際經營管理碩士班(IMBA) === 97 === Abstract A Study of M&A Trends and Effects on Global Pharmaceutical Industry: Using Bayer Schering Pharma as a Model By Sandy, Jui-San Lin The driving force for me to conduct a case writing related to M&A trends and effects in pharmaceutical indu...
Main Authors: | Lin, Sandy, 林芮珊 |
---|---|
Other Authors: | Wu, Jack |
Format: | Others |
Language: | en_US |
Published: |
2009
|
Online Access: | http://ndltd.ncl.edu.tw/handle/73254250827257188729 |
Similar Items
-
SPER 3 rd annual conference on "Recent trends in pharma industry: Bridging the gaps in pharmaceutical education"
by: Upendra Nagaich
Published: (2014-01-01) -
Pricing of Pharmaceutical Products in SME Pharma Units
by: Dr. J. K. Panda, et al.
Published: (2012-12-01) -
Schering STAR Program
by: Vince Andrijich, et al.
Published: (1998-11-01) -
Pharma TARP: A Troubled Asset Relief Program for Novel, Abandoned Projects in the Pharmaceutical Industry
by: Tamas Bartfai, et al.
Published: (2011-01-01) -
Mergers And Acquisitions Strategy In Vietnam Pharmaceutical Industry: A Case Study Of Vien Dong Pharma and Hataphar
by: HAI-HOANG NGUYEN, et al.
Published: (2011)